Living With HIV and Applying Today

Life insurance with HIV in the UK is available today from a number of mainstream insurers, and the honest starting point is that this is a very different question than it was a decade or two ago. If you have wondered whether you can get life insurance with HIV at all, the answer for most people on effective treatment is yes — through the ordinary market, not only through niche providers, and increasingly on terms that would have been unthinkable when the virus first appeared on an application form.

What has not changed is that it is still an underwritten decision. An insurer will want evidence, it will ask specific medical questions, and the terms you are offered depend on your particular history. This page is about the mechanics of that: what an insurer actually asks for, why the market moved, how the key numbers are read, and where a specialist referral fits if the mainstream route stalls. It is not about whether cover exists — it does — but about how the application works.

If you are applying because a mortgage, a partner or a child has made cover feel urgent, the practical steps below are the same whatever prompted the search. Life cover for people living with HIV is now a routine underwriting task, not a special case handled in a back room.

Why the market moved

For most of the history of HIV, insurers treated a diagnosis as close to uninsurable, because the outlook was genuinely poor. That reasoning no longer holds. Modern antiretroviral therapy has transformed the condition into a long-term, manageable one for people who are diagnosed in reasonable time and who take their medication consistently. The NHS guidance on HIV describes it as a condition most people now live a long and healthy life with, and recognises that someone on effective treatment who maintains an undetectable viral load cannot pass the virus on to sexual partners — the position often summarised as undetectable equals untransmittable.

Insurers price mortality risk, and when the underlying risk changes, pricing follows it, though usually with a lag. Over recent years UK insurers have reappraised HIV in exactly that way. Many now assess it much as they would another controlled long-term condition: not waved through without questions, but weighed on its facts rather than refused on sight. The result is a real, competitive market rather than a single specialist corner, which matters because competition is what gives you somewhere else to go if the first answer disappoints.

One practical consequence of the lag is that a good deal of the information you find online is out of date. Older articles, and older assumptions among friends and family, still carry the fear that a diagnosis ends the conversation. It does not, and it has not for some time. The change has also been uneven — different insurers reached different positions at different points — which is exactly why the market is worth treating as a market, and why a flat "you can't get cover" is almost never the correct answer now.

What the insurer actually asks for

An HIV application does not turn on a single question. Underwriters build a picture, and the pieces they ask for are consistent across insurers even where the conclusions differ. Expect questions about:

• The date of your diagnosis, and how it was picked up.
• Your treatment history — which antiretroviral medicines you have taken, any changes, and how consistently you take them.
• Your most recent CD4 count and viral load results, and often the trend across recent tests rather than a single reading.
• Whether you attend regular clinic reviews, and how stable your care has been.
• Any other conditions, related or not — mental health history, hepatitis co-infection, cardiovascular risk factors, smoking — because these are underwritten alongside, not instead of, the HIV.

To confirm the picture, an insurer will usually ask for medical evidence with your written consent: a targeted GP report, or a report from the HIV clinic that manages your care. This is routine, and the clinic letters that already sit in your records tend to answer most of what an underwriter needs. If the insurer asks you to help obtain your own records, our note on the insurer asking you to request your own records explains why that happens and what to do. The statute governing access to those reports differs in one part of the UK: England, Wales and Scotland use the Access to Medical Reports Act 1988, while Northern Ireland relies on the equivalent 1991 Order.

How CD4 count and viral load are read

Two numbers do most of the work in an HIV underwriting decision, and it is worth understanding what they signal.

Your viral load measures how much of the virus is detectable in your blood. An undetectable viral load, sustained on treatment, is the single most reassuring thing an underwriter can see. It says the medication is working and that you are taking it, and rather than being penalised for it you are credited with it. The phrase "undetectable viral load life insurance" turns up a lot in searches precisely because people fear the opposite — that any HIV marker counts against them. In practice the reverse is closer to the truth: a stable undetectable result is what opens the better terms.

Your CD4 count reflects the strength of your immune system. A healthy, stable CD4 count reinforces the same message. Underwriters generally prefer a track record to a single snapshot, so a run of good results over time carries more weight than one recent test. What draws further questions is instability — a viral load that has not been brought under control, a low or falling CD4 count, gaps in treatment, or a recent diagnosis where the picture has not yet settled. None of those is automatically a decline; they are reasons an insurer wants more information before it prices the risk.

Time since diagnosis matters too, but not in the way people fear. A very recent diagnosis can attract a short postponement, not because the outlook is poor but because the insurer wants to see treatment established and the numbers settle before committing to a price — a matter of months, typically, rather than a door closing. Once you have a period of stable, well-controlled results behind you, that early caution falls away. Where an application is postponed, the insurer normally states the period it wants to see before it will look again, so ask for that in writing rather than guessing at it.

When the first answer is not the market

The most important thing to carry into an HIV application is that insurers do not agree with each other. Appetite for this risk varies considerably — some insurers have leaned into it and written a lot of it, others remain cautious — so a decline or a heavy loading from one is a decision by that insurer, not a verdict from the industry. Applying again elsewhere is not gaming the system; it is using a market that genuinely differs.

This is where a broker earns their place. An adviser who regularly places HIV cases knows which insurers currently write the risk, how they like the medical evidence presented, and often can sound out an underwriter informally before a formal application is made. That does not remove underwriting or guarantee acceptance, but it materially improves the odds and spares you a trail of formal declines. If you are applying jointly with a partner and only one of you is straightforward, the sensible structure may not be a single joint policy — the trade-offs are in we applied together and only one of us was accepted.

Two related points are worth holding in view. If you have already been turned down and a later form asks whether you have ever had cover declined, you must answer it, and doing so rarely ends an application on its own — how to handle that question is set out in answering the "have you ever been declined" question honestly. And if the cover is needed to insure a business owner or a key individual rather than a family, the underwriting logic is the same but the framing differs, as in the key person the insurer will not cover.

Applying while you are between tests, and other timing questions

People often want to apply at an awkward moment — waiting on the next set of clinic results, or shortly after a change of medication. As a rule, insurers assess the picture as it stands and may ask to see the pending results before finalising terms, which can mean a short wait rather than a refusal. The general principles of applying before results are in, including when it helps to hold off, are covered in applying for cover while you wait for test results.

Be accurate about everything, not only the HIV. The duty under UK insurance law is to take reasonable care not to make a misrepresentation when the policy is set up, and that covers the whole form — units of alcohol, smoking status, other conditions. An accurate HIV disclosure sitting next to an understated answer elsewhere helps nobody. Honesty across the form is also what protects the payout years later, when a claim is assessed against what you said at the outset.

The cover to look at, and checking what you already have

Before applying for anything new, find out what you already hold. Many people have life cover through an employer's death-in-service scheme, which typically pays a multiple of salary and — crucially — is arranged on a group basis that needs no individual medical underwriting up to a set limit. For someone living with HIV that is valuable cover obtained without an application at all, and it is worth confirming its size before deciding how much extra you need.

If the cover is meant to protect a mortgage, check whether any protection was attached when you bought the home; our guide on how to find out today if your mortgage has life cover walks through it. The reason any of this matters is not abstract. When cover is missing and the worst happens, the family carries the shortfall, as the account in what one family faced with no life insurance sets out plainly. When you are ready to test the market, you can get life insurance quotes and, if your case is at all complex, ask for it to be placed by an FCA-authorised broker who handles HIV cases.

Once you are on cover

Getting accepted is the hard part; keeping the cover working is easy, and reassuring. A standard term policy is underwritten once, at the start, on the facts as they then stand. After that, changes in your health do not have to be reported and cannot be used to cancel or reprice guaranteed-premium cover. If your needs grow later — a bigger mortgage, another child — many policies carry a guaranteed insurability option that lets you raise the sum assured after certain life events without fresh medical questions, which is set out in raising your cover without new health questions.

If you want the wider context — how insurers treat a range of conditions, histories and occupations, and what leads to a rating rather than a decline — our hub on getting cover with a history, a condition or a job gathers it in one place. The single message to take from all of it is that an HIV diagnosis today is a fact to be underwritten, not a door that is closed.

Frequently asked questions

Can people with HIV get life insurance in the UK?

Yes. Cover is available from a number of UK insurers, and the market has changed substantially as treatment outcomes have improved. Terms depend on how long you have been diagnosed, your treatment and adherence, your CD4 count and viral load, and whether other health conditions sit alongside it. Most people on stable, effective treatment can obtain cover through the ordinary market.

What evidence will the insurer want?

Typically your date of diagnosis, current and previous treatment, recent CD4 count and viral load results, whether you attend regular clinic reviews, and details of any related or unrelated conditions. A consented GP report, or a report from your HIV clinic, is often requested to confirm the picture rather than relying on the application form alone.

What if the first insurer says no?

Appetite differs considerably here, so a single decision is not the market. A broker who regularly places HIV cases will know which insurers currently write this risk and how the evidence should be presented, which improves the odds without guaranteeing acceptance. Employer death-in-service cover, where you have it, needs no individual underwriting and is worth confirming first.